Search
for
Sort by
Research 151–180 of 509
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
- Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women
- Comparison of finasteride versus flutamide in the treatment of hirsutism
- PCOS in adolescents
- Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors
- Polycystic ovary syndrome and impact on health
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
- How should postmenopausal androgen excess be evaluated?
- Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance
- Ovarian Hypertension: Polycystic Ovary Syndrome
- Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Androgens in women
- Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome
- The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*
- The therapeutic use of androgens in women
- Idiopathic Hirsutism*
- Androgen receptor gene polymorphism and polycystic ovary syndrome
- Androgen receptor gene CAG repeat polymorphism in women with polycystic ovary syndrome
- Evidence-based approach to cutaneous hyperandrogenism in women
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- Cutaneous Side Effects of Oral Contraceptives
- Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome
- Polycystic ovary syndrome (PCOS)
- Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess
- Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam’s criteria and women whose only clinical signs are oligo/anovulation or hirsutism